Christian Mauriand is the Founder and Chairman of KANOMA Capital. Prior to KANOMA Capital, Christian was an early team member at Roivant Sciences (NASDAQ: ROIV) where he last served as Global Head of Corporate Development participating in over $10Bn in transactions and various listings of portfolio companies to both NASDAQ and NYSE. 

Prior to joining Roivant, Christian co-founded iRewind, a technology company which was sold to Yoveo in 2016. An Executive Committee member of The Swiss Private Equity & Corporate Finance Association (SECA), the representative body for Switzerland‘s private equity, venture capital and corporate finance industries, Christian holds a BA in Business Administration from the University of St. Gallen

Justin Kim is a Principal at KANOMA Capital. Prior to joining KANOMA Capital, he worked with Christian on the corporate development team at Roivant Sciences (NASDAQ: ROIV), where he participated in ~$10B in transactions. Prior to his time at Roivant, he worked in BD at Oncoceutics, a series A biotech, which he helped sell to Chimerix (NASDAQ: CMRX). Prior to Oncoceutics, he was a business development and M&A consultant at ZS Associates. He holds dual bachelor degrees in Biology from the University of Pennsylvania and Economics from the Wharton School.

David Orban is an Analyst at KANOMA Capital. Prior to joining KANOMA Capital, he completed an internship at Deloitte, where he focused on real estate valuations and market research. He is also the Founder and CEO of The Société Anonyme Europe, a venture that has delivered large-scale international events.

He holds a BSc in Business Management from Bayes Business School and a Master in Real Estate Development from IE Business School, with a concentration in real estate finance, business strategy, and market analytics.